Cancer, Chemosensitivity Testing, IPT, Poly-MVA

Thank you, everyone. Thank you, Frank and Lorraine, as usual, putting on a wonderful meeting. We always learn something at these alternative meetings when my wife and I attend conventional medicine meetings. After four or five days, we sit, look at each other, say, did we learn anything here? So usually the answer is no. I also want to thank the two ALS Al Senior and Al Junior Sanchez, both at opposite ends of the exhibit room, down the down the stairs for all their support and their backing to be with my poly MBA studies and and other products that they represent. And also think any brand who is the CEO of the ICP, which is the International Organization for Integrative Cancer Physicians. We had our meeting there in April in Reno and we will have next year's meeting already scheduled at the Silver Legacy Hotel in Reno in April of next year, 2015. So any herself as a long term cancer survivor, 14 years. And she has an amazing story to tell.

So let's all remember this. Oh, there are greater than five hundred thousand deaths per year in the United States from cancer. I think this is often forgotten and lost. We were so upset with Ebola, which has killed 15000 in Western Africa, but that's only one thirtieth of the amount of people who die each year of cancer in the United States.

And then think about the Malaysian airplane that went down in the Indian Ocean with approximately 250 patients. Five hundred thousand divided by two is two hundred and fifty thousand. That equates to 1000 jumbo jets going down through about three a day in the United States for a year. That's how many lives we lose every year because of conventional oncology. They're able to save only two point one percent at five years. Five years of chemotherapy for adult cancers in their own journals, the American Journal of Clinical Oncology. A retrospective study which was duplicated in Australia, two point one percent survival and two point three percent in Australia. So very similar statistics. So think about that and 250000 patients, because in our projected study, we're looking at at least a 50 percent survival right now. As you'll see from our statistics, we have 50 months out on our study started in June of 2010, and we are having a 67 percent survival in those patients, all stage four cancers.

What I've done many studies over the years, I had to jump the fence and after my education goes back to UC Berkeley and UC San Francisco and then into the Army, I was in the Army for twenty six years.